PARIS (Reuters) -French drugmaker Sanofi said on Monday it had entered exclusive talks to sell a 50% controlling stake in its ...
The US buyout firm is pairing with the French pharma giant to buy out its consumer unit. Success here requires much more than ...
GlobalData on MSN3d
Sanofi’s $17bn sale of Opella to US investors advances following government dealA stake by France-owned Bpifrance and promise of local job retention have allayed political backlash over the sale of ...
Sanofi is in talks with CD&R to sell a 50% stake in its consumer healthcare unit, Opella. PAI Partners raised its bid by 200 ...
After a year-long takeover battle for the owner of France’s best-selling painkiller, Sanofi’s decision to sell its ...
Sanofi said on Monday it had entered exclusive talks for the sale of a 50% controlling stake in its consumer health business ...
After a year-long takeover battle for the owner of France’s best-selling painkiller, Sanofi’s decision to sell its over ...
M&A activity continues to be strong across sectors, and this is expected to translate into better performance for small caps, ...
PAI partners has submitted an improved bid for Sanofi’s consumer health business, in an attempt to re-enter the race for what ...
PAI partners submitted an improved bid for Sanofi's consumer health business, in an attempt to reenter the race for what could be one of the pharma industry's biggest deals this year. The French ...
Sanofi SA (NASDAQ:SNY) and private equity Clayton Dubilier & Rice (CD&R) have finally entered into exclusive negotiations to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback